O	0	3	The
O	4	15	Progression
O	16	18	of
B-Disease	19	29	Geographic
I-Disease	30	37	Atrophy
O	38	47	Secondary
O	48	50	to
B-Disease	51	54	Age
I-Disease	54	55	-
I-Disease	55	62	Related
I-Disease	63	70	Macular
I-Disease	71	83	Degeneration
O	83	84	.

B-Disease	86	96	Geographic
I-Disease	97	104	atrophy
O	105	106	(
B-Disease	106	108	GA
O	108	109	)
O	110	112	is
O	113	115	an
O	116	124	advanced
O	125	129	form
O	130	132	of
B-Disease	133	136	age
I-Disease	136	137	-
I-Disease	137	144	related
I-Disease	145	152	macular
I-Disease	153	165	degeneration
O	166	167	(
B-Disease	167	170	AMD
O	170	171	)
O	172	176	that
O	177	182	leads
O	183	185	to
O	186	197	progressive
O	198	201	and
B-Symptom	202	214	irreversible
I-Symptom	215	219	loss
I-Symptom	220	222	of
I-Symptom	223	229	visual
I-Symptom	230	238	function
O	238	239	.

B-Disease	240	250	Geographic
I-Disease	251	258	atrophy
O	259	261	is
O	262	269	defined
O	270	272	by
O	273	276	the
O	277	285	presence
O	286	288	of
B-Symptom	289	296	sharply
I-Symptom	297	307	demarcated
I-Symptom	308	316	atrophic
I-Symptom	317	324	lesions
I-Symptom	325	327	of
I-Symptom	328	331	the
I-Symptom	332	337	outer
I-Symptom	338	344	retina
O	344	345	,
O	346	355	resulting
O	356	360	from
B-Symptom	361	365	loss
I-Symptom	366	368	of
I-Symptom	369	383	photoreceptors
I-Symptom	383	384	,
I-Symptom	385	392	retinal
I-Symptom	393	400	pigment
I-Symptom	401	411	epithelium
I-Symptom	412	413	(
I-Symptom	413	416	RPE
I-Symptom	416	417	)
I-Symptom	417	418	,
I-Symptom	419	422	and
I-Symptom	423	433	underlying
I-Symptom	434	450	choriocapillaris
O	450	451	.

O	452	457	These
O	458	465	lesions
O	466	475	typically
O	476	482	appear
O	483	488	first
O	489	491	in
O	492	495	the
B-Anatomy	496	506	perifoveal
I-Anatomy	507	513	macula
O	513	514	,
O	515	524	initially
O	525	532	sparing
O	533	536	the
B-Anatomy	537	543	foveal
I-Anatomy	544	550	center
O	550	551	,
O	552	555	and
O	556	560	over
O	561	565	time
O	566	571	often
O	572	578	expand
O	579	582	and
O	583	591	coalesce
O	592	594	to
O	595	602	include
O	603	606	the
B-Anatomy	607	612	fovea
O	612	613	.

O	614	622	Although
O	623	626	the
O	627	635	kinetics
O	636	638	of
B-Disease	639	641	GA
O	642	653	progression
O	654	657	are
O	658	664	highly
O	665	673	variable
O	674	679	among
O	680	690	individual
O	691	699	patients
O	699	700	,
O	701	702	a
O	703	710	growing
O	711	715	body
O	716	718	of
O	719	727	evidence
O	728	736	suggests
O	737	741	that
O	742	750	specific
O	751	766	characteristics
O	767	770	may
O	771	773	be
O	774	783	important
O	784	786	in
O	787	797	predicting
O	798	805	disease
O	806	817	progression
O	818	821	and
O	822	830	outcomes
O	830	831	.

O	832	836	This
O	837	843	review
O	844	855	synthesizes
O	856	863	current
O	864	877	understanding
O	878	880	of
B-Disease	881	883	GA
O	884	895	progression
O	896	898	in
B-Disease	899	902	AMD
O	903	906	and
O	907	910	the
O	911	918	factors
O	919	924	known
O	925	927	or
O	928	938	postulated
O	939	941	to
O	942	944	be
O	945	953	relevant
O	954	956	to
B-Symptom	957	959	GA
I-Symptom	960	966	lesion
I-Symptom	967	978	enlargement
O	978	979	,
O	980	989	including
O	990	994	both
O	995	1003	affected
O	1004	1007	and
O	1008	1014	fellow
B-Anatomy	1015	1018	eye
O	1019	1034	characteristics
O	1034	1035	.

O	1036	1038	In
O	1039	1047	addition
O	1047	1048	,
O	1049	1052	the
O	1053	1058	roles
O	1059	1061	of
O	1062	1069	genetic
O	1069	1070	,
O	1071	1084	environmental
O	1084	1085	,
O	1086	1089	and
O	1090	1101	demographic
O	1102	1109	factors
O	1110	1112	in
B-Symptom	1113	1115	GA
I-Symptom	1116	1122	lesion
O	1123	1134	enlargement
O	1135	1138	are
O	1139	1148	discussed
O	1148	1149	.

O	1150	1157	Overall
O	1157	1158	,
B-Disease	1159	1161	GA
O	1162	1173	progression
O	1174	1179	rates
O	1180	1188	reported
O	1189	1191	in
O	1192	1195	the
O	1196	1206	literature
O	1207	1210	for
O	1211	1216	total
O	1217	1222	study
O	1223	1234	populations
O	1235	1240	range
O	1241	1245	from
O	1246	1247	0
O	1247	1248	.
O	1248	1250	53
O	1251	1253	to
O	1254	1255	2
O	1255	1256	.
O	1256	1257	6
O	1258	1260	mm
O	1261	1262	2
